KALA BIO, INC. Restricted Cash and Cash Equivalents, Noncurrent
KALA BIO, INC. (KALA) had Restricted Cash and Cash Equivalents, Noncurrent of $700.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2022-03-29
- 2021-12-31: Restricted Cash and Cash Equivalents, Noncurrent $700.00K.
- 2021-09-30: Restricted Cash and Cash Equivalents, Noncurrent $2.74M.
- 2021-06-30: Restricted Cash and Cash Equivalents, Noncurrent $2.74M.
- 2021-03-31: Restricted Cash and Cash Equivalents, Noncurrent $12.49M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2021-12-31 | $700.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $2.74M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.74M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $12.49M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $12.49M 10-K · filed 2022-03-29 |
| 2020-09-30 | $12.59M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $12.58M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $12.58M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $12.58M 10-K · filed 2021-02-25 |
| 2019-09-30 | $12.58M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $12.58M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $12.57M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $12.21M 10-K · filed 2020-02-12 |
| 2018-09-30 | $2.18M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $2.18M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $2.18M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $134.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $133.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $134.00K 10-Q · filed 2017-08-31 |
| 2016-12-31 | $109.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |